Company Analysis TerrAscend Corp.
1. Summary
Advantages
- Price (2.19 $) is less than fair price (2.38 $)
- The stock's return over the last year (0%) is higher than the sector average (-10.48%).
Disadvantages
- Dividends (0%) are below the sector average (1.53%).
- Current debt level 35.73% has increased over 5 years from 18.07%.
- The company's current efficiency (ROE=-119.97%) is lower than the sector average (ROE=13.27%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
TerrAscend Corp. | Healthcare | Index | |
---|---|---|---|
7 days | 0% | -10.9% | -0.4% |
90 days | 0% | -6.4% | -3.9% |
1 year | 0% | -10.5% | 9.1% |
TRSSF vs Sector: TerrAscend Corp. has outperformed the "Healthcare" sector by 10.48% over the past year.
TRSSF vs Market: TerrAscend Corp. has significantly underperformed the market by -9.15% over the past year.
Stable price: TRSSF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: TRSSF with weekly volatility of 0% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (2.19 $) is lower than the fair price (2.38 $).
Price not significantly lower than the fair price: The current price (2.19 $) is slightly lower than the fair price by 8.7%.
4.2. P/E
P/E vs Sector: The company's P/E (7.12) is lower than that of the sector as a whole (31.39).
P/E vs Market: The company's P/E (7.12) is lower than that of the market as a whole (53.25).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.9135) is lower than that of the sector as a whole (3.11).
P/BV vs Market: The company's P/BV (0.9135) is higher than that of the market as a whole (-8.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.18) is lower than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (1.18) is lower than that of the market as a whole (4.72).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-1.87) is lower than that of the sector as a whole (10.15).
EV/Ebitda vs Market: The company's EV/Ebitda (-1.87) is lower than that of the market as a whole (28.41).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 33.34% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (33.34%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-27.73%).
5.4. ROE
ROE vs Sector: The company's ROE (-119.97%) is lower than that of the sector as a whole (13.27%).
ROE vs Market: The company's ROE (-119.97%) is lower than that of the market as a whole (4.93%).
5.5. ROA
ROA vs Sector: The company's ROA (-50.7%) is lower than that of the sector as a whole (6.22%).
ROA vs Market: The company's ROA (-50.7%) is lower than that of the market as a whole (16.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (2.83%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (2.83%) is lower than that of the market as a whole (11.06%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.53%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription